Grow your business safely with SELARL PHARMACIE KERROS

All the information you need about SELARL PHARMACIE KERROS to develop and secure your business in France

S HOME > CORPORATES > SELARL PHARMACIE KERROS > BALANCE SHEET ( 2021-11-19)

THE LIST OF BALANCE SHEET : SELARL PHARMACIE KERROS

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-10-03 Partially confidential 2022-03-31 Complete
2021-11-19 Partially confidential 2021-03-31 Complete
2020-12-28 Partially confidential 2020-03-31 Complete
2019-10-07 Partially confidential 2019-03-31 Complete
2018-10-04 Partially confidential 2018-03-31 Complete
2017-10-31 Partially confidential 2017-03-31 Complete
NameSELARL PHARMACIE KERROS
Siren811693936
Closing2021-03-31
Registry code 2901
Registration number 5314
Management number2015D00217
Activity code 4773Z
Closing date n-12020-03-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2021-11-19
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPartially confidential
Address29200 Brest
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AF Concessions, Patents and Similar Rights 6 554.00 990.00 5 563.00 6 554.00
AH Goodwill 1 264 997.00 1 264 997.00 1 264 997.00
AR Technical installations, industrial equipment and tools 2 195.00 2 195.00 2 195.00
AT Other tangible assets 158 060.00 87 514.00 70 546.00 158 060.00
BH Other financial assets 160.00 160.00 160.00
BJ TOTAL (I) 1 433 066.00 90 700.00 1 342 366.00 1 433 066.00
BT Goods 145 131.00 145 131.00 145 131.00
BX Customers and related accounts 19 800.00 19 800.00 19 800.00
BZ Other receivables 94 134.00 94 134.00 94 134.00
CD Marketable securities 106 600.00 106 600.00 106 600.00
CF Cash and cash equivalents 20 695.00 20 695.00 20 695.00
CH Prepaid expenses 2 562.00 2 562.00 2 562.00
CJ TOTAL (II) 388 924.00 388 924.00 388 924.00
CO Grand total (0 to V) 1 821 990.00 90 700.00 1 731 290.00 1 821 990.00
CU Other investments 1 099.00 1 099.00 1 099.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 915 000.00 915 000.00 915 000.00
DD Legal reserve (1) 14 606.00 14 549.00 14 606.00
DG Other reserves 275 945.00 274 862.00 275 945.00
DI RESULTS FOR THE YEAR (Profit or Loss) 3 472.00 1 140.00 3 472.00
DL TOTAL (I) 1 209 023.00 1 205 551.00 1 209 023.00
DU Loans and Debts from Credit Institutions (3) 324 870.00 313 338.00 324 870.00
DV Miscellaneous Loans and Financial Debts (4) 58 361.00 59 941.00 58 361.00
DX Trade payables and related accounts 75 957.00 78 192.00 75 957.00
DY Tax and social security liabilities 63 077.00 52 141.00 63 077.00
EC TOTAL (IV) 522 266.00 503 614.00 522 266.00
EE Grand total (I to V) 1 731 290.00 1 709 166.00 1 731 290.00
EG Accrued income and payables due within one year 281 603.00 196 916.00 281 603.00
EH Including current bank overdrafts and credit balances from banks and postal accounts 6 277.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 75 957.00 75 957.00 75 957.00
8C Staff and Related Accounts 22 317.00 22 317.00 22 317.00
8D Social Security and Other Social Organizations 29 629.00 29 629.00 29 629.00
UT Other financial assets 160.00 160.00 160.00
UX Other trade receivables 19 800.00 19 800.00 19 800.00
VB VAT 11 286.00 11 286.00 11 286.00
VH Loans with a maturity of more than one year at origin 324 871.00 84 207.00 240 663.00 324 871.00
VI Group and Associates 58 361.00 58 361.00 58 361.00
VM Income taxes 4 289.00 4 289.00 4 289.00
VQ Other Taxes, Duties, and Similar Debts 1 095.00 1 095.00 1 095.00
VR Miscellaneous debtors (including receivables related to repo transactions) 78 559.00 78 559.00 78 559.00
VS Prepaid expenses 2 563.00 2 563.00 2 563.00
VT TOTAL – STATEMENT OF RECEIVABLES 116 657.00 116 657.00 116 657.00
VY TOTAL – STATEMENT OF LIABILITIES 512 230.00 271 566.00 240 663.00 512 230.00

all companies in France

Complete and comprehensive database.